Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-28 4:15 pm Purchase |
2023-07-18 | 13D | Apogee Therapeutics, Inc. APGE |
Venrock Healthcare Capital Partners III L.P. | 3,887,478 9.990% |
3,887,478 (New Position) |
Filing |